The Lacuna Project

lacuna (n.) a gap in a record where something should be

Independent research. Not affiliated with any government, agency, or company.

Exhibit 142

Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization: Guidance for Industry

Exhibit 142 ยท Agency guidance

Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization: Guidance for Industry

FDA lacks the resources to pursue enforcement against every product that has not received authorization.

States that all new tobacco products marketed without authorization are illegally marketed, then sets out that FDA generally does not intend to prioritize enforcement against unauthorized e-cigarettes and nicotine pouches whose applications have been accepted and filed, or whose supplemental applications have been pending for more than 180 days. Non-tobacco-flavored e-cigarettes qualify if FDA has determined the application contains the data needed for public-health review. Products with youth-appealing features or greater safety concerns remain enforcement priorities. FDA will publish a list of the products it does not intend to prioritize.

Source
U.S. Food and Drug Administration, Center for Tobacco Products
Date
May 2026
Quoted from
Section II, p. 4
Grade
Primary record
Document
https://www.fda.gov/media/192403/download
Accessed
2026-11-09
Cited by
Findings citing this exhibit

Cited by

Finding MED-6.7
Primary record In May 2026 FDA stopped prioritizing enforcement against unauthorized e-cigarettes and nicotine pouches with pending applications. Medical and public health groups sued in July.